Drug shortage: Remifentanil Hydrochloride Injection (ULTIVA, REMIFENTANIL HYDROCHLORIDE)
FDA lists 9 presentations as Current. Availability: Unavailable (4), Available (5). Reason: Demand increase for the drug; Delay in shipping of the drug. Companies: Mylan Institutional, a Viatris Company, Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA, Inc..
- Published by source
- 2022-06-28
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-29
Affected
- Manufacturer
- Mylan Institutional, a Viatris Company
- Products
- Remifentanil Hydrochloride Injection ULTIVA REMIFENTANIL HYDROCHLORIDE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Check wholesalers for inventory
- Estimated recovery: TBD
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2022-06-28
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #873 | new | 2026-10-22 | 8249d2c02759…0686d1 | 2396e20923a9…8b0b8d |
| #1161 | update | 2026-10-23 | 0668de950318…3d455c | c505aadf92de…de04f7 |
| #1395 | update | 2026-10-23 | 3daf1dd23e94…b59465 | 7775744a16dd…2a641a |
| #2216 | update | 2026-10-27 | 5138347b2756…cd0691 | 2a6cfdd544c3…a4b1de |
| #2437 | update | 2026-10-27 | 96c0d5cdec71…77356a | 67b05556ff72…1ef563 |
| #2608 | update | 2026-10-28 | 1d96d5a51035…499efb | 8f4494125d83…08b0d2 |
| #2706 | update | 2026-10-28 | 389f451f2769…f45232 | 2caa927c6164…a4a05c |
| #2824 | update | 2026-10-29 | fae5cccdad88…e40dad | cd426f5a009f…5d8aba |
Chain head: #2934 7db06885a062…766e76